Amgen (AMGN) revenue

Revenue · fiscal 2025
$36.75B

Amgen (AMGN) reported revenue of $36.75B in fiscal 2025 (the year ended December 31, 2025). That is 10.0% higher than the $33.42B of fiscal 2024. Figures as of 18 Nov 2026, 10:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$36.75B
Change on fiscal 2024
+10.0%
Growth, 5 years
+7.6% a year
Growth, 10 years
+5.4% a year
Highest on record
$36.75Bfiscal 2025
Lowest on record
$14.64Bfiscal 2009
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Amgen revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 7.6% a year; over ten years the rate was 5.4% a year. Across the 19 fiscal years on record (2007–2025), the highest was $36.75B in fiscal 2025 and the lowest $14.64B in fiscal 2009.

History · 19 fiscal years

Revenue by fiscal year

Amgen revenue, year by year

Amgen (AMGN) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$36.75B 10.0% up
2024$33.42B 18.6% up
2023$28.19B 7.1% up
2022$26.32B 1.3% up
2021$25.98B 2.2% up
2020$25.42B 8.8% up
2019$23.36B 1.6% down
2018$23.75B 3.9% up
2017$22.85B 0.6% down
2016$22.99B 6.1% up
2015$21.66B 8.0% up
2014$20.06B 7.4% up
2013$18.68B 8.2% up
2012$17.27B 10.8% up
2011$15.58B 3.5% up
2010$15.05B 2.8% up
2009$14.64B 2.4% down
2008$15.00B 1.6% up
2007$14.77B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Amgen and comparable companies
CompanyRevenueFiscal year
Novartis NVS$56.67B2025
AstraZeneca AZN$58.74B2025
Thermo Fisher Scientific TMO$44.56B2025
Amgen AMGN$36.75B2025
Abbott Laboratories ABT$44.33B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on AMGN

Amgen, figure by figure

Amgen (AMGN) overview: price, valuation and scorecardAll health care companies by market value

Amgen revenue: questions and answers

What is Amgen's revenue?

Amgen (AMGN) reported revenue of $36.75B in fiscal 2025 (the year ended December 31, 2025). That is 10.0% higher than the $33.42B of fiscal 2024.

What is the growth rate of Amgen's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 7.6% a year; over ten years the rate was 5.4% a year.

What are the highest and lowest revenue figures on record for Amgen?

Across the 19 fiscal years on record (2007–2025), the highest was $36.75B in fiscal 2025 and the lowest $14.64B in fiscal 2009.

How is Amgen's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Amgen it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Amgen (AMGN) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/AMGN/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.